Monthly Archives: December 2017

With surveillance gaps, Angola sees microcephaly incidence rise over months following Zika confirmation

By on .

The first cluster of microcephaly cases just outside Angola’s capital city was noticed in September of this year, marking nine months since tests in January had confirmed the virus in a sick adult, and in a stillborn infant with neurological defects. A WHO bulletin now says cases in the area had surfaced in May and […]

Ebola stories highlight global health security needs, efforts, progress in emerging infections detection, prevention, response

By on .

In 2014, as international health leaders and policy makers launched the Global Health Security Agenda to meet increasingly urgent needs to prevent, detect and respond to infectious disease outbreaks around the world, the emergence of the Ebola crisis in West Africa underscored the immediacy of their mission. Spreading from a forest in Guinea to sweep […]

Study finds Zika virus in semen up to five months after symptom onset among returning infected travelers

By on .

Among men infected with Zika while visiting the Americas, the median time the virus remained after being detected in their semen was nearly three months, a study of infected travelers returning to Belgium has found. Zika was found in semen samples from nine of 15 men who participated in the study, including in the semen […]

What we’re reading: World AIDS Day messages with urgency every day, and more

By on .

Progress toward ending the HIV epidemic is challenged by threats to ACA – In a timely call for accountability, Chair of the HIV Medicine Association Dr. Melanie Thompson describes here how political battles to undermine the Affordable Care Act also undermine resources needed to win the war against HIV at home. Dr. Thompson, who also […]

Analysis: Trump PEPFAR strategy, budget proposals add up to surrender in HIV battle

By on .

White House proposals to slash more than a billion dollars from U.S. supported HIV responses and limit efforts to control the epidemic to a handful of countries represents an unprecedented retreat from American leadership of the global fight against the disease and would reverse gains that were achieved, at a cost of more than $80 […]